NDC 87063-180 – Cevimeline Hydrochloride

Cevimeline Hydrochloride 30 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC87063-180

Product details

Brand name
Cevimeline Hydrochloride
Generic name
Cevimeline Hydrochloride
Labeler
ASCLEMED USA INC.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA203775
Marketed since
June 17, 2014
Listing expires
December 31, 2027
Pharmacologic class
Cholinergic Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Cevimeline hydrochloride →

Package NDC codes (4)

Package NDCDescriptionSince
87063-180-01100 CAPSULE in 1 BOTTLE (87063-180-01)May 18, 2026
87063-180-3030 CAPSULE in 1 BOTTLE (87063-180-30)May 18, 2026
87063-180-6060 CAPSULE in 1 BOTTLE (87063-180-60)May 18, 2026
87063-180-9090 CAPSULE in 1 BOTTLE (87063-180-90)May 18, 2026

Other Cevimeline hydrochloride products